Gene editing is at the centre of the next generation of biotechnology. By changing the messages encoded within DNA sequences, it creates new possibilities for researchers to unravel questions ...

Precision BioSciences is a clinical-stage gene-editing company focused on the development of cell and gene therapies to treat cancer and genetic causes of disease. The company’s pipeline of ...

Nexiguran ziclumeran (nex-z) is an investigational therapy based on CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats and associated Cas9 endonuclease) targeting the gene ...